Predicting Factors for Stent Failure-Free Survival in Patients With a Malignant Ureteral Obstruction Managed With Ureteral Stents
유성현, 유제국, Jeong Se-Heon, 황의창, 장원석, 유호송, 김선옥, 정승일, 강택원, 권동득, 박광성, 황준일, 김근수, 황인상,
소속 상세정보
유성현 ( Yu Seong-Hyeon )
Chonnam National University Medical School Department of Urology
유제국 ( Ryu Je-Guk )
Chonnam National University Medical School Department of Urology
( Jeong Se-Heon )
Chonnam National University Medical School Department of Urology
황의창 ( Hwang Eu-Chang )
Chonnam National University Medical School Department of Urology
장원석 ( Jang Won-Seok )
Chonnam National University Medical School Department of Urology
유호송 ( Yu Ho-Song )
Chonnam National University Medical School Department of Urology
김선옥 ( Kim Sun-Ouck )
Chonnam National University Medical School Department of Urology
정승일 ( Jung Seung-Il )
Chonnam National University Medical School Department of Urology
강택원 ( Kang Taek-Won )
Chonnam National University Medical School Department of Urology
권동득 ( Kwon Dong-Deuk )
Chonnam National University Medical School Department of Urology
박광성 ( Park Kwang-Sung )
Chonnam National University Medical School Department of Urology
황준일 ( Hwang Jun-Eul )
Chonnam National University Medical School Department of Hematology-Oncology
김근수 ( Kim Geun-Soo )
Gwangju Hospital Department of Urology
황인상 ( Hwang In-Sang )
Chonnam National University Medical School Department of Urology
KMID : 0358320130540050316
Abstract
Purpose: To determine predictive factors for stent failure-free survival in patients treated with a retrograde ureteral stent for a malignant ureteral obstruction.
Materials and Methods: We retrospectively reviewed 71 patients who underwent insertion of a cystoscopic ureteral stent due to a malignant ureteral obstruction between May 2004 and June 2011. Performance status, type of cancer, hydronephrosis grade, location of the obstruction, presence of bladder invasion, C-reactive protein (CRP), serum albumin, and inflammation-based prognostic score (Glasgow prognostic score, GPS) were assessed using a Cox proportional regression hazard model as predicting factors for stent failure.
Results: A univariate analysis indicted that hypoalbuminemia (<3.5 g/dL; hazard ratio [HR], 2.43; 95% confidence interval [CI], 1.21 to 4.86; p=0.012), elevated CRP (≥1 mg/dL; HR, 4.79; 95% CI, 2.0 to 11.1; p=0.001), and presence of a distal ureter obstruction (HR, 3.27; 95% CI, 1.19 to 8.95; p=0.021) were associated with stent failure-free survival. A multivariate analysis revealed that the presence of a mid and lower ureteral obstruction (HR, 3.27; 95% CI, 1.19 to 8.95; p=0.007), GPS ≥1 (HR, 7.22; 95% CI, 2.89 to 18.0; p=0.001), and elevated serum creatinine before ureteral stent placement (>1.2 mg/dL; HR, 2.16; 95% CI, 1.02 to 4.57; p=0.044) were associated with stent failure-free survival.
Conclusions: A mid or lower ureteral obstruction, GPS ≥1, and serum creatinine before ureteral stent insertion >1.2 mg/dL were unfavorable predictors of stent failure-free survival. These factors may help urologists predict survival time.
키워드
Neoplasm metastasis;Stents;Ureteral obstruction
원문 및 링크아웃 정보
등재저널 정보